Hydroxyapatite-coated femoral stem survivorship at 10 years.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 16214004.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ninety-six patients were implanted with the Omnifit-HA femoral stem and the Omnifit-PSL porous-coated dual-radius acetabular shell (Stryker, Mahwah, NJ) and liners that were sterilized by gamma-radiation in air. The mean age at the time of surgery was 52 years (range, 27-78 years), and male/female ratio was 54:42. The mean follow-up was 10.3 years (range, 7-12 years). The survivorship of the stem and cup was 100% and 90%, respectively. Four cups were revised for aseptic loosening, and 6 liners were exchanged. The mean polyethylene wear rate was 0.24 mm/y. Lysis was noted in 23% of the cups. No patient developed femoral lysis distally. This hydroxyapatite-coated stem continues to perform well and appears to protect against the migration of wear debris along the femoral stem.
Medical subject headings
- Biocompatible Materials
- Durapatite
- Hip Prosthesis
Anatomy
- femur
- hip